What is the main business of Medisolutions?

The main business activity of Medisolutions focuses on retail sale of medical and orthopaedic goods in specialised stores.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on May 26, 2022.

Where is the headquarters located?

The headquarters is located at: ul. Adama Branickiego 15, 02-972 Warszawa.

What is the share capital?

The share capital of the company is PLN 10,000 (approx. $2,701).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

How much revenue was generated?

In 2025, the company generated total revenue of $59,549, representing a decrease of 65.0% compared to 2024.

Yes, in 2025 the company was profitable, achieving a net profit of $2,185, meaning the company decreased its profit by 97.2%.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to $31,096 in 2025, representing 57% of all operating expenses.

Medisolutionssp. z o.o.

Retail sale of medical and orthopaedic goods in specialised stores

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-05-26

Share capital

10,000.00 PLN

Activity description

Medisolutions provides pharmaceutical marketing services for Rx and OTC medicines, dietary supplements, and medical devices. Its services include marketing strategies and campaigns, digital marketing, and GenAI implementation and training for pharmaceutical companies.

Registered address

ul. Adama Branickiego 15, 02-972 Warszawa, Poland

Website

medisolutions.com.pl

Phone

Social media

Financials

Revenue history (in k)

Filing timeliness

3 of 4 financial statements were filed late (the longest delay 3 days for 2022).

202501/06/2026
202418/07/2025
202318/07/2024
202218/07/2023

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 59.55kMedianUSD 344.45kAverageUSD 2.51m

Net profit

This companyUSD 2.19kMedianUSD 14.41kAverageUSD 165.58k

Operating costs

This companyUSD 54.40kMedianUSD 298.04kAverageUSD 2.27m

Assets

This companyUSD 80.45kMedianUSD 201.82kAverageUSD 1.23m

Industry

Offer

Marketing strategy
Marketing campaign
Digital marketing
Marketing automation
Influencer marketing
Pharmaceutical marketing
GenAI training

Website technology

Online shop

WooCommerce

Website

WordPress

Authorized Representatives

Magdalena Anna Wojtyniak – Management Board Member

Marek Jerzy Wojtyniak – Management Board Member

Manner of representation

Each member of the management board is authorised to make declarations on behalf of the company independently

Ownership

Owner	Shares	Share value	Stake
Magdalena Anna Wojtyniakage 55	90	$2,431.12	90%
Marek Jerzy Wojtyniakage 57	10	$270.12	10%

Magdalena Anna Wojtyniak and Marek Jerzy Wojtyniak hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2022-07-09.

ING Bank Śląski
57 1050 1025 1000 0090 8162 1832
ING Bank Śląski
35 1050 1025 1000 0090 8162 1840

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Medical Smart Integratorsp. z o.o.	$317,541.89	medicalsmartintegrator.pl
Online Conceptsp. z o.o.	$167,382.14	onlineconcept.pl
Biomi-Farmsp. z o.o.	$152,446.44	biomi-farm.pl
Spiderxsp. z o.o.	$15,672.27	spiderx.pl

FAQ

Last updated: 2026-07-14